Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EmOpti
EmOpti

EmOpti

Series A

EmOpti: Providing comprehensive software, hardware, and telehealth solutions for emergency medicine.

HQ
Brookfield, WI, US
Founded
2015
Overview
Compare
Fundraising
Employees

Founded with a mission to revolutionize emergency medicine, EmOpti offers comprehensive software, hardware, and telehealth solutions. The company focuses on optimizing clinical workflows, leveraging machine learning and AI to enhance performance analytics and patient outcomes. EmOpti's market focus includes healthcare providers seeking to address staff challenges, expedite patient flow, and improve overall care through innovative virtual care models.

EmOpti has garnered attention for its impactful contributions to emergency medicine, with notable affiliations including leading healthcare providers and industry experts. The company has achieved significant milestones in clinical workflow optimization, evidenced by successful case studies and white papers. EmOpti's solutions have made a measurable impact on patient care efficiency and staff productivity, positioning it as a leader in the healthcare technology sector.

EmOpti - Similar Companies

Optain logo

Optain

optainhealth.com

MedClimate logo

MedClimate

Frame Health logo

Frame Health

framehealth.com

TeleQ logo

TeleQ

Cerebro Solutions logo

Cerebro Solutions

kelaHealth logo

kelaHealth

kelahealth.com

Opticyte logo

Opticyte

opticyte.com

Digital Medical Tech logo

Digital Medical Tech

Aiva logo

Aiva

aiva.ai

OptMed logo

OptMed

optmed.com

Handl Health logo

Handl Health

gohandlhealth.com

Deep 6 AI logo

Deep 6 AI

deep6.ai

Optimal Solutions logo

Optimal Solutions

Insight Optics logo

Insight Optics

io.care

Opticent Health logo

Opticent Health

opticenthealth.com

EmOpti - Quick Facts

Who are EmOpti's competitors?

Companies similar to EmOpti include Optain, MedClimate, Frame Health and TeleQ.

When was EmOpti founded?

EmOpti was founded in 2015.

Where is EmOpti's headquarters located?

EmOpti's headquarters is located in Brookfield, WI, US.

How much has EmOpti raised to-date?

As of Aug 4, 2021, EmOpti has raised a total of $7.4M (USD).

How many employees does EmOpti have?

EmOpti has 17 employees as of Feb 5, 2024.

EmOpti - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Hardware
  • Software
Tags
  • Consulting
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software